Using the information from the decision tree, that is, having identified the coagulopathy present, the specific values generated by the TEG® system are used in the Treatment Guide to arrive at a therapy decision. Several TEG® tests are categorized, so that not only is the type of treatment identified, but a suggested dosage is presented to help guide therapy.

Hemostasis state	Common treatment
clotting factors	x 2 FFP or 8 ml/kg
clotting factors	x 4 FFP or 16 ml/kg
platelet function	.3mg/kg DDAVP
platelet function	x5 platelet units
platelet function	x10 platelet units
fibrinogen level	.06 u/kg cryo
Primary fibrinolysis	antifibrinolytic of choice
Secondary fibrinolysis	anticoagulant of choice
Prothrombotic state	anticoagulant of choice

For example, clotting factors are characterized as slightly lower and greatly lower than normal based on the TEG® R test, and the R test results are given ranges to determine optimal treatment levels for clotting factor disorders.

Each of these treatment suggestions are supported by multiple peer-reviewed articles written by users of the TEG® system, and are available from Haemoscope Corporation or your local representative.

<< Back